Alzheimer's Association Welcomes U.S. FDA Approval of Kisunla (donanemab)

“Today’s decision by the FDA is good news for those of us living with early Alzheimer’s,” said Barbara Eades, of Chattanooga, Tennessee, who was …

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 96% regionally and is currently trending positive.


Media Trust Score100%